Provided by Tiger Trade Technology Pte. Ltd.

TJ DaRenTang USD

3.260
-0.040-1.21%
Volume:106.40K
Turnover:350.38K
Market Cap:2.51B
PE:8.02
High:3.340
Open:3.300
Low:3.230
Close:3.300
52wk High:3.750
52wk Low:1.786
Shares:770.00M
Float Shares:421.34M
Volume Ratio:0.48
T/O Rate:0.03%
Dividend:0.70
Dividend Rate:21.57%
EPS(TTM):0.407
EPS(LYR):0.407
ROE:28.24%
ROA:5.11%
PB:2.41
PE(LYR):8.02

Loading ...

Tianjin Pharmaceutical Da Ren Tang Group Proposes New Independent Director

SGX Filings
·
Apr 16

Tianjin Pharmaceutical Da Ren Tang seeks green light for about 586 million Singapore dollars of new guarantees

SGX Filings
·
Apr 02

Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20%

MT Newswires
·
Mar 31

Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Down 4% in 2025

MT Newswires
·
Mar 31

Stock Track | TJ DaRenTang USD Soars 3.65% Intraday on Strong Profitability Metrics and New Shareholder Return Plan

Stock Track
·
Mar 31

Tianjin Pharmaceutical Da Ren Tang proposes S$589 million guarantees for affiliates

SGX Filings
·
Mar 30

Tianjin Pharmaceutical Da Ren Tang releases semi-annual risk report on group finance subsidiary

SGX Filings
·
Mar 30

Tianjin Pharmaceutical Da Ren Tang Appoints New Representative for A-Share Placement Oversight

SGX Filings
·
Mar 24

Tianjin Pharmaceutical Da Ren Tang Group Provides February Update on Subsidiary Bankruptcy

SGX Filings
·
Feb 27

SGX Weekly Review | STI up 0.6%; TJ DaRenTang, POP MART HK SDR Soar 12%; SingaporeLandGrp Rises 10%; SMIC HK SDR, Tencent HK SDR Drop 9%

TigerNews SG
·
Feb 07

Stock Track | TJ DaRenTang USD Soars 3.44% as Controlling Shareholder Increases Stake

Stock Track
·
Feb 06

Controlling Shareholder Ups Stake in Tianjin Pharmaceutical Da Ren Tang; Shares Up 3%

MT Newswires
·
Feb 06

Tianjin Pharmaceutical Da Ren Tang’s parent adds to Singapore-listed stake, plans further buys

SGX Filings
·
Feb 05

Tianjin Pharmaceutical Da Ren Tang Group Issues January Update on Subsidiary Bankruptcy Proceedings

SGX Filings
·
Jan 30

Tianjin Pharmaceutical Da Ren Tang Group issues December update on subsidiary’s bankruptcy liquidation

SGX Filings
·
Dec 31, 2025

Tianjin Pharmaceutical Da Ren Tang provides monthly update on subsidiary’s bankruptcy process

SGX Filings
·
Nov 28, 2025

Tianjin Pharmaceutical Da Ren Tang receives Chinese approval for loxoprofen pain patch

SGX Filings
·
Nov 25, 2025

Tianjin Pharmaceutical Da Ren Tang's Unit Granted Registration Certificate by Chinese Authority

MT Newswires
·
Nov 25, 2025

Tianjin Pharmaceutical Da Ren Tang Group to Host Online Briefing on 9-Month 2025 Results

SGX Filings
·
Nov 24, 2025

Tianjin Pharmaceutical Da Ren Tang posts RMB224.6 m third-quarter profit, lifts nine-month earnings to RMB2.15 bn on disposal gain

SGX Filings
·
Oct 30, 2025